Coverage
-
October 28, 2024
A Delaware bankruptcy judge approved DMK Pharmaceuticals' Chapter 11 liquidation plan on Monday, resolving objections from the U.S. Trustee's Office and the unsecured creditors' committee, and aiming to settle approximately $15 million in claims brought by the U.S. Department of Justice.
2 other articles on this case.
View all »